Tsumura & Co.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 5 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
972.0K | +1.96% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
622.7K | +4.20% | |
|
Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.
|
489.1K | +11.16% | |
|
Templeton Global Smaller Companies Fund
|
479.3K | 0.00% | |
|
Victory Portfolios-Victory Trivalent International Small-Cap Fund
|
435.6K | +0.90% | |
|
Bridge Builder Trust-Bridge Builder International Equity Fund
|
428.2K | +1.88% |
Dividend History 3Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥136 | +15.3% |
| 2024 | ¥118 | +76.1% |
| 2023 | ¥67 | +4.7% |
| 2022 | ¥64 | 0.0% |
| 2021 | ¥64 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥129,546M | ¥140,043M | ¥150,845M | ¥181,093M |
| Gross Profit | ¥66,465M | ¥68,281M | ¥68,816M | ¥90,583M |
| Operating Income | ¥22,377M | ¥20,916M | ¥20,017M | ¥40,125M |
| Pretax Income | ¥25,736M | ¥23,274M | ¥24,066M | ¥46,077M |
| Net Income | ¥18,836M | ¥16,482M | ¥16,707M | ¥32,428M |
| EPS | ¥246.21 | ¥215.63 | ¥219.83 | ¥427.15 |
| Operating Margin | 17.27% | 14.94% | 13.27% | 22.16% |
| Balance Sheet | ||||
| Total Assets | ¥350,981M | ¥396,813M | ¥428,254M | ¥464,380M |
| Total Equity | ¥239,769M | ¥252,045M | ¥270,801M | ¥300,528M |
| Total Liabilities | ¥111,212M | ¥144,768M | ¥157,453M | ¥163,852M |
| Cash | ¥67,552M | ¥94,752M | ¥78,075M | ¥73,227M |
| Interest-bearing Debt | ¥49,690M | ¥79,690M | ¥79,690M | ¥70,336M |
| Equity Ratio | 68.31% | 63.52% | 63.23% | 64.72% |
| D/E Ratio | 0.21 | 0.32 | 0.29 | 0.23 |
| Cash Flow | ||||
| Operating CF | ¥21,314M | ¥16,452M | ¥5,608M | ¥33,823M |
| Investing CF | -¥9,111M | -¥15,493M | -¥19,351M | -¥24,974M |
| Financing CF | -¥8,181M | ¥24,423M | -¥4,417M | -¥19,871M |
| Free CF | ¥10,727M | ¥1,744M | -¥14,449M | ¥4,029M |
| Efficiency | ||||
| ROE | 7.86% | 6.54% | 6.17% | 10.79% |
| ROA | 5.37% | 4.15% | 3.90% | 6.98% |
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥4,508
Rating Score: - (Based on 5 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan.
